• Demystifying Highly Potent API And Cytotoxic Drug Products

    Capturing the right information early demystifies the development process, especially for drugs with HPAPI components. Gathering, organizing, and understanding critical risk data related to HPAPIs and cytotoxic drugs ensures appropriate controls are defined from concept to clinical batch manufacturing to commercial-scale manufacturing. 

  • mRNA - The Vaccine Technology Explained In Short

    With two mRNA-based COVID-19 vaccines coming to market, this innovative platform is delivering on its promise of a safer, faster, more efficacious approach to vaccine manufacturing. mRNA has the potential to revolutionize the vaccine industry and hold a promising pipeline ranging from cancer application to indications with unmet needs such as HIV or Zika. Watch this brief video and explore the science behind mRNA vaccines.

  • 3 Ways To Mitigate Data Manipulation Risk In Drug Development

    A critical output of the drug development process, besides the compound itself, is data. We highlight specific actions to mitigate your organization’s risk of data manipulation and three key steps in tackling this problem.

  • Delivering Macromolecules: Challenges Associated With The Delivery Of Biologic Drugs

    Developers need to look beyond the formulation of a stable drug all the way to patient compliance. Numerous pitfalls exist along the journey to bring a biologic combination product to market. This integrated solutions program can help you simplify the journey.

  • Debunking Myths And Misconceptions About Softgels

    Here, we take a look at some common myths about softgels and explore why drug developers may want to reconsider their go-to delivery methods.


  • Micro Ultracentrifuges

    This unique floor-standing model is suitable to be installed at central and/ or shared laboratory together with other expensive and large laboratory devices, so that many laboratories can share CS-FNX series.

  • Small Molecule API Brochure

    Ensure that you always have the exact resources and expertise you need, especially for your most difficult to manufacture compounds.

  • Particle Control In Biopharmaceuticals

    Successful drug product development should integrate formulation, manufacturing process, primary packaging, device and delivery to the patient. Lonza’s Drug Product Services (DPS) offering delivers a holistic approach to DP development that anticipates and prevents problems early, and ensures the result is a product that is fit for purpose.

  • CR22N High-Speed Refrigerated Centrifuge

    The Hitachi Koki model himac CR22N High-Speed Refrigerated Centrifuge offers reliable performance with a maximum RCF of 55,200xg and capacity of 6L for bottles, tubes, or microplates. Patented features such as the Automatic Rotor Identification and Rotor Cover Detector make the CR22N the ideal separation tool for multiple research applications involving DNA, RNA, viruses, proteins, and more.

  • Softgel Technologies Brochure

    Innovative softgel technologies that maximize your market potential: Where ideation and expertise come together.